rawpixel-shutterstock-com-3-
Rawpixel / Shutterstock.com
28 July 2016Big Pharma

Sanofi and Boehringer Ingelheim to swap businesses

Sanofi and Boehringer Ingelheim have reached an agreement to swap parts of their business.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
12 January 2021   Sanofi will buy British immunotherapy firm Kymab for up to $1.45 billion, as it seeks to expand in the rapidly growing immunotherapy field.

More on this story

Big Pharma
12 January 2021   Sanofi will buy British immunotherapy firm Kymab for up to $1.45 billion, as it seeks to expand in the rapidly growing immunotherapy field.

More on this story

Big Pharma
12 January 2021   Sanofi will buy British immunotherapy firm Kymab for up to $1.45 billion, as it seeks to expand in the rapidly growing immunotherapy field.